Us Congress Senate Bill SB1631

Us Congress 2025-2026 Regular Session

Caption

A bill to require the Secretary of Health and Human Services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved, and for other purposes.